Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon.

@article{Latagliata2006AcuteML,
  title={Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon.},
  author={Roberto Latagliata and Velia Bongarzoni and Ida Carmosino and Andrea Mengarelli and Massimo Breccia and Paola Anticoli Borza and Mariella D'Andrea and Gianna Maria D'Elia and Sergio Mecarocci and Salvatore Giacomo Morano and Maria Concetta Petti and Franco Mandelli and Giuliana Alimena},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2006},
  volume={17 2},
  pages={281-5}
}
BACKGROUND Acute Myelogenous Leukemia (AML) is a common disease in people aged>60 years. About 50% of the patients are not eligible for aggressive chemotherapy (CT) and are only managed with conservative approaches. Results in this subset of patients have not been reported so far. PATIENTS AND METHODS We retrospectively evaluated 244 consecutive elderly AML patients (M/F 143/101, median age 72 years, range 60-90) diagnosed at our institution from January 1989 to December 1998 and not eligible… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…